A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Da Costa, PharmD
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- the Ottawa Hospital-Cancer Centre
Ottawa, Ontario, Canada
- University of California Los Angeles
Los Angeles, California, United States
- Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Parkview Research Center
Fort Wayne, Indiana, United States
- Baptist Health Lexington
Lexington, Kentucky, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Karmanos Cancer Institute
Detroit, Michigan, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- Metrohealth Medical Center
Cleveland, Ohio, United States
- University Hospitals Case Medical Center
Cleveland, Ohio, United States
- Greenville Health System Cancer Institute
Greenville, South Carolina, United States
- Mary Crowley Medical Research Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2016
- Primary completion
- 12 Sept 2018
- Completion
- 12 Sept 2018
- Last update posted
- 24 Sept 2018
- Registered enrollment
- 46
- Registry id
- NCT02874664
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.